|
**Update: The
settlement was approved on October 7, 2009.**
There is a Class Action Settlement with Pfizer Inc. (“Pfizer”) concerning
the prescription drugs Bextra and Celebrex. You may have previously received information
about this case. The name of the lawsuit is In re Bextra and Celebrex Marketing,
Sales Practices and Products Liability Litigation, No. M:05-cv-01699-CRB,
pending in the United States District Court for the Northern District of California.
This lawsuit claims that Pfizer falsely advertised and/or marketed the drugs Celebrex
and Bextra as having greater benefits than less expensive pain medicines and in
contradiction to the drugs’ Food and Drug Administration approved labeling. Pfizer
has agreed to pay a total of $89 million to settle this lawsuit. Pfizer denies any
wrongdoing and denies all of the claims in the lawsuit, but it is settling to avoid
the costs and distraction of further litigation.
|
If you are a Consumer and you paid (or are obligated to pay) for
Bextra and/or Celebrex on or before July 29, 2005 please
click here to read detailed information.
|
|
If you are a Third-Party Payors (TPP) who reimbursed or paid for
Bextra and/or Celebrex on or before July 29, 2005 please click
here to read detailed information.
|
If you are a Canadian resident, please visit www.bextracelebrexsettlement.ca for information on the Canadian
BextraCelebrex Litigation Settlement Agreement.
|